Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigms.

Balko JM, Arteaga CL
Mol Diagn Ther. 2012 16 (1): 1-6

PMID: 22339590 · DOI:10.1007/BF03256423

MeSH Terms (5)

Antineoplastic Agents Biomarkers, Tumor Cytogenetic Analysis Humans Lung Neoplasms

Connections (3)

This publication is referenced by other Labnodes entities:

Links